CREST Findings on Angiographic Characteristics Contributing to Periprocedural CAS Stroke and Death Risk Published
April 20, 2016—The higher stroke and death (S+D) risk for patients treated with carotid artery stenting (CAS) in CREST, the Carotid Revascularization Endarterectomy Versus Stenting Trial, appears to be largely isolated to those patients with longer lesion length and/or those with sequential and remote lesions, reported Wesley S. Moore, MD, et al on behalf of the CREST investigators in the Journal of Vascular Surgery (JVS, 2016;63:851–858). In the absence of those lesion characteristics, CAS appears to be as safe as carotid endarterectomy (CEA) with regard to periprocedural risk of S+D, concluded the CREST investigators.
